Achievements have been made in the development of pharmaceutical innovation in China since the Chinese Communist Party's 18th National Congress. China is moving toward from follow-on innovation to the original innovation. This paper reviews current situation of the drug innovation, analyzes the existing problems and obstacles, and puts forward corresponding suggestions. New challenges for the future of pharmaceutical innovation include lower innovative capability, risk of dependence on foreign technological in some key chains, lack of top pharmaceutical companies in the world, etc. Several suggestions for resolving these capital, talent, technology, system, and policy problems are proposed as follows: taking advantage of the new system for mobilizing resources nationwide, improving the efficiency of innovation investment, coordination of talent attraction policies and science and technology policies, developing industry-university-institute-hospital R&D, perfecting related policy and ecosystem environment.

pharmaceutical innovation  /  National Significant Scientific and Technological Project for "Drug Innovation"  /  science and technology innovation